Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
AMRI has been named as the exclusive supplier of the API in Cassiopea SpA’s recently approved acne treatment, Winlevi cream 1%.
read more
Wednesday, October 21, 2020
Vifor and Cara announced both companies have signed a license agreement for commercialization of Korsuva (difelikefalin) Injection.
read more
Wednesday, October 07, 2020
BIAL and Recipharm, have expanded a long-term agreement for the global manufacturing and supply of BIAL’s proprietary molecule opicapone.
read more
Wednesday, September 30, 2020
Hovione announced the signing of a partnership agreement with Ligand to ramp up the production output of Captisol.
read more
Monday, September 28, 2020
Samsung Biologics has entered into a service agreement with Panolos Bioscience to develop PB101, an Fc-fusion protein intended to treat solid tumors.
read more
Monday, September 07, 2020
PAI announced the company has been awarded a three-year contract from HealthTrust Purchasing Group as a supplier of pharmaceutical products to its Membership nationwide.
read more
Monday, September 07, 2020
PPD and LT have entered into a collaboration to expand and enhance lupus clinical research for PPD’s pharmaceutical and biotech customers.
read more
Friday, September 04, 2020
RedHill announced the selection of opaganib1 for severe COVID-19 pneumonia.
read more
Wednesday, September 02, 2020
The FDA and the FTC has issued a warning letter to Lattice Biologics for marketing an unapproved amniotic fluid product, sometimes referred to as AmnioBoost.
read more
Tuesday, September 01, 2020
Gilead Sciences announced an agreement with Jounce Therapeutics to exclusively license its JTX-1811 program.
read more
Tuesday, September 01, 2020
The NCCN Oncology Research Program announced plans to develop a program to scientifically evaluate and facilitate clinical trials on the efficacy of decitabine and cedazuridine.
read more
Wednesday, August 26, 2020
MediWound and Vericel announced the BARDA has accepted the first shipment of NexoBrid
read more
Albek de Mexico is voluntarily recalling all lots and all brands of hand sanitizer currently in US distribution to the consumer level.
read more
Processa has entered into a licensing agreement with Yuhan, a South Korean based company, to license in YH12852.
read more
Tetra has awarded the contract for the manufacturing of its API, HU-308, and of the intravenous, sterile, finished drug product ARDS-003 to Dalton.
read more